Blog
Wall Street Bulls Look Optimistic About SharkNinja, Inc. (SN): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Brokers Suggest Investing in Gray Media (GTN): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Is It Worth Investing in MINISO Group Holding Limited (MNSO) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Is It Worth Investing in Cisco (CSCO) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Urogen Pharma (URGN) Reports Q1 Loss, Beats Revenue Estimates
Urogen Pharma (URGN) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to a loss of $0.92 per share a year ago. These figures
Here's What Key Metrics Tell Us About Amcor (AMCR) Q3 Earnings
For the quarter ended March 2026, Amcor (AMCR) reported revenue of $5.91 billion, up 77.4% over the same period last year. EPS came in at $0.96, compared to $0.90 in the year-ago quarter.
The
Trinity Capital (TRIN) Surpasses Q1 Earnings and Revenue Estimates
Trinity Capital (TRIN) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.52 per share a year ago. These
Bloomin' Brands (BLMN) Reports Q1 Earnings: What Key Metrics Have to Say
For the quarter ended March 2026, Bloomin' Brands (BLMN) reported revenue of $1.06 billion, up 1% over the same period last year. EPS came in at $0.67, compared to $0.59 in the year-ago quarter.
The
Brokers Suggest Investing in Chewy (CHWY): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Is It Worth Investing in Datadog (DDOG) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
F5 (FFIV) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended March 2026, F5 Networks (FFIV) reported revenue of $811.7 million, up 11% over the same period last year. EPS came in at $3.90, compared to $3.42 in the year-ago quarter.
The
One Stop Systems, Inc. (OSS) Beats Q1 Earnings and Revenue Estimates
One Stop Systems, Inc. (OSS) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to a loss of $0.07 per share a year
Compared to Estimates, Dine Brands (DIN) Q1 Earnings: A Look at Key Metrics
For the quarter ended March 2026, Dine Brands (DIN) reported revenue of $225.2 million, up 4.9% over the same period last year. EPS came in at $1.07, compared to $1.03 in the year-ago quarter.
The
Is It Worth Investing in Palantir Technologies (PLTR) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
MPLX LP (MPLX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
MPLX LP (MPLX) reported $3.04 billion in revenue for the quarter ended March 2026, representing a year-over-year decline of 2.8%. EPS of $0.90 for the same period compares to $1.10 a year ago.
The
New York Times (NYT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended March 2026, New York Times Co. (NYT) reported revenue of $712.24 million, up 12% over the same period last year. EPS came in at $0.61, compared to $0.41 in the year-ago
Novavax (NVAX) Reports Q1 Loss, Beats Revenue Estimates
Novavax (NVAX) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to earnings of $2.93 per share a year ago. These figures are
Is It Worth Investing in Petrobras (PBR) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
APTIV PLC (APTV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Aptiv PLC (APTV) reported $5.09 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 5.4%. EPS of $1.71 for the same period compares to $1.69 a year ago.
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.4 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.7 per share a year ago
Brokers Suggest Investing in Nu (NU): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
fuboTV Inc. (FUBO) Reports Q2 Loss, Lags Revenue Estimates
fuboTV Inc. (FUBO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.24 per share a year ago. These figures are
Here's What Key Metrics Tell Us About IQVIA (IQV) Q1 Earnings
For the quarter ended March 2026, IQVIA Holdings (IQV) reported revenue of $4.15 billion, up 8.4% over the same period last year. EPS came in at $2.90, compared to $2.70 in the year-ago quarter.
The
BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Beats Revenue Estimates
BioCryst Pharmaceuticals (BCRX) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of $0.06. This compares to break-even earnings per share a year ago. These
Solventum (SOLV) Recently Broke Out Above the 50-Day Moving Average
From a technical perspective, Solventum (SOLV) is looking like an interesting pick, as it just reached a key level of support. SOLV recently overtook the 50-day moving average, and this suggests a


